Drug recall · July 19, 2023
Albuterol Sulfate Inhalation Aerosol recall
Why: Defective container: empty inhaler and leakage observed through the inhaler valve due to partially missing bottom seat (gasket).
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Albuterol Sulfate Inhalation Aerosol, 90 mcg, 200 Metered Inhalation, net content 6.7 g canister packaged in a box, Rx only, Manufactured by: Cipla Ltd, Indore SE Z, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ, 07059, NDC 69097-142-60
- Lots / codes
Lot # IB20045, IB20055, IB20056, IB20057, IB20059, IB20072, Exp Nov. 30, 2023
- Quantity
- 278,538 canisters
- Company
- Cipla USA, Inc., Warren, NJ
- Distribution
- Nationwide in the US
- Initiated
- June 27, 2023 · Voluntary: Firm initiated
- Classified
- July 21, 2023
- Reported
- July 19, 2023
- Ended
- March 6, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Albuterol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.